Antimyosin scintigraphy in cardiovascular diseases
- 1 September 1992
- journal article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 2 (5) , 197-204
- https://doi.org/10.1016/1050-1738(92)90049-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Detection of experimental myocarditis by monoclonal antimyosin antibody, Fab fragmentAmerican Heart Journal, 1989
- A comparative study of myocardial infarct detection using Tc99m pyrophosphate and In111 DTPA antimyosin (R11D10 Fab)The International Journal of Cardiovascular Imaging, 1987
- Increased incidence and clinical correlation of persistently abnormal technetium pyrophosphate myocardial scintigrams following acute myocardial infarction in patients with diabetes mellitusAmerican Heart Journal, 1982
- Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies.Circulation, 1979
- Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments.Circulation, 1978
- Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin.Circulation, 1978
- Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization.Circulation, 1977
- Clinicopathologic study of persistently positive technetium-99m stannous pyrophosphate myocardial scintigrams and myocytolytic degeneration after myocardial infarction.Circulation, 1977
- Acute myocardial infarction and ischemic injury during surgery for coronary artery diseaseAmerican Heart Journal, 1977
- The speed of healing of myocardial infarctionAmerican Heart Journal, 1939